Blood Thinners Reduce Covid Deaths By 50%, Hospitalisation By 43%: US Study

The research was conducted on 6,195 patients over the age of 18 who were diagnosed with Covid between March 4 and August 27, 2020 across 12 hospitals and 60 clinics in the US.

Covid patients who use blood thinners may have a nearly 50% reduced risk of death and a 43% lower risk of hospitalisation, according to a study published in Lancet's EClinicalMedicine journal.

The research was conducted on 6,195 patients over the age of 18 who were diagnosed with Covid between March 4 and August 27, 2020 across 12 hospitals and 60 clinics in the US.

The researchers from US' University of Minnesota and Basel University in Switzerland analysed the relationship between 90-day anti-coagulation therapy among out-patients before Covid-19 diagnosis and the risk for hospitalisation and mortality.

The researchers also evaluated the association between anti-coagulation therapy, which is used to prevent blood clots, and mortality risk among admitted patients.